These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17924742)

  • 1. TASC II section F on revascularization in PAD.
    Norgren L; Hiatt WR; Harris KA; Lammer J;
    J Endovasc Ther; 2007 Oct; 14(5):743-4. PubMed ID: 17924742
    [No Abstract]   [Full Text] [Related]  

  • 2. TASC II section F on revascularization: commentary from an interventionist's point of view.
    Schillinger M; Diehm N; Baumgartner I; Minar E
    J Endovasc Ther; 2007 Oct; 14(5):734-42. PubMed ID: 17924741
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical follow-up in endovascular treatment for TASC C-D lesions in femoro-popliteal segment.
    Rabellino M; Zander T; Baldi S; Garcia Nielsen L; Aragon-Sanchez FJ; Zerolo I; Llorens R; Maynar M
    Catheter Cardiovasc Interv; 2009 Apr; 73(5):701-5. PubMed ID: 19309709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial clinical experience with the 4-F self-expanding XPERT stent system for infrapopliteal treatment of patients with severe claudication and critical limb ischemia.
    Kickuth R; Keo HH; Triller J; Ludwig K; Do DD
    J Vasc Interv Radiol; 2007 Jun; 18(6):703-8. PubMed ID: 17538131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating the diseased superficial femoral artery.
    Gibbs JM; Peña CS; Benenati JF
    Tech Vasc Interv Radiol; 2010 Mar; 13(1):37-42. PubMed ID: 20123431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermittent claudication due to peripheral artery disease: best modern medical and endovascular therapeutic approaches.
    Kobayashi T; Parikh SA; Giri J
    Curr Cardiol Rep; 2015 Oct; 17(10):86. PubMed ID: 26280273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of lower-extremity revascularization.
    Friedell ML; Stark KR; Kujath SW; Carter RR
    Curr Probl Surg; 2014 Jun; 51(6):254-90. PubMed ID: 24863077
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful lower extremity angioplasty improves brachial artery flow-mediated dilation in patients with peripheral arterial disease.
    Husmann M; Dörffler-Melly J; Kalka C; Diehm N; Baumgartner I; Silvestro A
    J Vasc Surg; 2008 Nov; 48(5):1211-6. PubMed ID: 18771886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Length matters: outcomes of superficial femoral artery (SFA) endovascular interventions.
    Hillegass WB
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1096. PubMed ID: 19953522
    [No Abstract]   [Full Text] [Related]  

  • 10. Below-the-knee revascularization. Advanced techniques.
    SCHWARZWALDER U; ZELLER T
    J Cardiovasc Surg (Torino); 2009 Oct; 50(5):627-34. PubMed ID: 19741578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical practice. Intermittent claudication.
    White C
    N Engl J Med; 2007 Mar; 356(12):1241-50. PubMed ID: 17377162
    [No Abstract]   [Full Text] [Related]  

  • 12. Medical and endovascular management of critical limb ischemia.
    Lumsden AB; Davies MG; Peden EK
    J Endovasc Ther; 2009 Apr; 16(2 Suppl 2):II31-62. PubMed ID: 19624074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral arterial disease.
    Hills AJ; Shalhoub J; Shepherd AC; Davies AH
    Br J Hosp Med (Lond); 2009 Oct; 70(10):560-5. PubMed ID: 19966700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Particularities of peripheral arterial disease managed in vascular surgery in the French West Indies.
    Deneuville M; Pierrot JM; N'guyen R
    Arch Cardiovasc Dis; 2008 Jan; 101(1):23-9. PubMed ID: 18391869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirolimus for below the knee lesions: mid-term results of SiroBTK study.
    Commeau P; Barragan P; Roquebert PO
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):793-8. PubMed ID: 17039538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective stenting in subintimal angioplasty: analysis of primary stent outcomes.
    Schmieder GC; Richardson AI; Scott EC; Stokes GK; Meier GH; Panneton JM
    J Vasc Surg; 2008 Nov; 48(5):1175-80; discussion 1180-1. PubMed ID: 18778911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined percutaneous endovascular iliac angioplasty and infrainguinal surgical revascularization for chronic lower extremity ischemia: preliminary result.
    Mousa A; Abdel-Hamid M; Ewida A; Saad M; Sahrabi A
    Vascular; 2010; 18(2):71-6. PubMed ID: 20338130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease.
    Rocha-Singh KJ; Jaff MR; Crabtree TR; Bloch DA; Ansel G;
    Catheter Cardiovasc Interv; 2007 May; 69(6):910-9. PubMed ID: 17377972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of peripheral arterial disease of the lower extremities.
    Aronow WS
    Compr Ther; 2007; 33(4):247-56. PubMed ID: 18025617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of disabling intermittent claudication in patients with superficial femoral artery occlusive disease--decision analysis.
    Nolan B; Finlayson S; Tosteson A; Powell R; Cronenwett J
    J Vasc Surg; 2007 Jun; 45(6):1179-84. PubMed ID: 17543682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.